Non Hodgkin Lymphoma (NHL)
Showing 1 - 7 of 7
Non Hodgkin Lymphoma (NHL), Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL) Trial in Milwaukee (8/12-Day
Recruiting
- Non Hodgkin Lymphoma (NHL)
- +6 more
- 8/12-Day Production of Car-T Cells
- +2 more
-
Milwaukee, WisconsinMedical College of Wisconsin and Froedtert Hospital
Jul 1, 2022
Acute Lymphoblastic Leukemia (ALL), Non Hodgkin Lymphoma (NHL) Trial in Zhengzhou, Hangzhou (CD19-UCART)
Recruiting
- Acute Lymphoblastic Leukemia (ALL)
- Non Hodgkin Lymphoma (NHL)
- CD19-UCART
-
Zhengzhou, Henan, China
- +1 more
Apr 2, 2022
Non Hodgkin Lymphoma (NHL), Diffuse Large B-cell Lymphoma (DLBCL) Trial in United States (rituximab, prednisone, Geriatric
Active, not recruiting
- Non Hodgkin Lymphoma (NHL)
- Diffuse Large B-cell Lymphoma (DLBCL)
- rituximab
- +2 more
-
Basking Ridge, New Jersey
- +7 more
Mar 9, 2022
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), MDS (MDS) Trial in Memphis (drug, biological, device)
Recruiting
- Acute Lymphoblastic Leukemia (ALL)
- +7 more
- Cyclophosphamide
- +11 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 8, 2021
Non-interventional, Long-term Follow-up of Subjects Who
Unknown status
- Acute Myelogenous Leukemia (AML)
- +3 more
- non intervational
-
Haifa, IsraelRambam Medical Center
Nov 24, 2019
Non Hodgkin Lymphoma (NHL) Trial in Praha
Recruiting
- Non Hodgkin Lymphoma (NHL)
-
Praha, CzechiaCharles University General Hospital
Jun 21, 2017